U.S. federal trademark · Serial No. 87240794
Biosimilar pharmaceutical preparation, namely, a granulocyte colony-stimulating factor analog used to stimulate the proliferation and differentiation of granulocytes for use with chemotherapy regimens to lessen the incidence of chemotherapy-induced neutropenia
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.